APGRX
Price
$24.99
Change
+$0.33 (+1.34%)
Updated
Sep 11 closing price
Net Assets
124.93M
RLLGX
Price
$85.88
Change
+$0.27 (+0.32%)
Updated
Sep 11 closing price
Net Assets
91.39B
Interact to see
Advertisement

APGRX vs RLLGX

APGRX vs RLLGX Comparison Chart in %
View a ticker or compare two or three
VS
APGRX vs. RLLGX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGRX is a Buy and RLLGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLLGX has more cash in the bank: 91.4B vs. APGRX (125M). RLLGX pays higher dividends than APGRX: RLLGX (0.88) vs APGRX (0.00). APGRX was incepted earlier than RLLGX: APGRX (13 years) vs RLLGX (17 years). APGRX (1.28) is less costly to investors than RLLGX (0.65). RLLGX is a more actively managed with annual turnover of: 41.00 vs. APGRX (38.00). RLLGX has a lower initial minimum investment than APGRX: RLLGX (250) vs APGRX (1000000). APGRX annual gain was more profitable for investors over the last year : 10.93 vs. RLLGX (9.55). APGRX return over 5 years is better than : 7.94 vs. RLLGX (-7.42).
APGRXRLLGXAPGRX / RLLGX
Total Expense Ratio1.260.65194%
Annual Report Gross Expense Ratio1.280.65197%
Fund Existence13 years17 years-
Gain YTD11.93812.57095%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets125M91.4B0%
Annual Yield % from dividends0.000.88-
Returns for 1 year10.939.55114%
Returns for 3 years48.7439.24124%
Returns for 5 years7.94-7.42-107%
Returns for 10 years60.3190.5467%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIEYX17.51N/A
N/A
GuideStone Funds International Eq Instl
SHRAX91.15N/A
N/A
ClearBridge Growth A
EAGCX16.22N/A
N/A
Eaton Vance Atlanta Capital Focused Gr C
TEIHX52.46N/A
N/A
Nuveen Equity Index I
BCEMX33.55N/A
N/A
Boston Common ESG Impact Em Mkts